These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3860370)

  • 21. Specific lysis of Plasmodium yoelii infected mouse erythrocytes with antibody and complement.
    Gabriel J; Berzins K
    Clin Exp Immunol; 1983 Apr; 52(1):129-34. PubMed ID: 6861370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity.
    Seaman WE; Talal N; Herzenberg LA; Herzenberg LA; Ledbetter JA
    J Immunol; 1981 Sep; 127(3):982-6. PubMed ID: 6790624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on natural killer (NK) cells. II. Serologic evidence for heterogeneity of murine NK cells.
    Burton RC; Bartlett SP; Kumar V; Winn HJ
    J Immunol; 1981 Nov; 127(5):1864-8. PubMed ID: 6975301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
    Gorin NC; Douay L; Laporte JP; Lopez M; Zittoun R; Rio B; David R; Stachowiak J; Jansen J; Cazellas P
    Cancer Treat Rep; 1985 Sep; 69(9):953-9. PubMed ID: 3896482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures.
    Colombatti M; Nabholz M; Gros O; Bron C
    J Immunol; 1983 Dec; 131(6):3091-5. PubMed ID: 6139402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
    Fulton RJ; Uhr JW; Vitetta ES
    J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [C. Friend leukemia as a model of erythroid differentiation].
    Hradilek A; Ponka P
    Cesk Fysiol; 1979; 28(4):333-58. PubMed ID: 292513
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunotoxins].
    Jansen FK; Blythman HE; Carrière D; Casellas P; Dussossoy D; Gros O; Gros P; Laurent JC; Paolucci F; Pau B; Poncelet P; Richer G; Vidal H; Voisin GA
    Bull Cancer; 1983; 70(3):165-8. PubMed ID: 6882931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Present potential of immunotoxins.
    Poncelet P; Blythman HE; Carriere D; Casellas P; Dussossoy D; Gros O; Gros P; Jansen FK; Laurent JC; Liance MC
    Behring Inst Mitt; 1984 May; (74):94-100. PubMed ID: 6383330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 38. Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions.
    Grant CK; Ernisse BJ; Jarrett O; Jones FR
    J Immunol; 1983 Dec; 131(6):3042-8. PubMed ID: 6196410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin.
    Foxwell BM; Ross WC; Thorpe PE
    Behring Inst Mitt; 1984 May; (74):101-7. PubMed ID: 6477350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.